Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Depression
2018 Standout
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
2011 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting
2003
The Efficacy of Postoperative Ondansetron (Zofran??) Orally Disintegrating Tablets for Preventing Nausea and Vomiting After Acoustic Neuroma Surgery
2005
Optimising antiemetic therapy: what are the problems and how can they be overcome?
2005
Effectiveness-implementation Hybrid Designs
2012 Standout
Risk?benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting
2004
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
2011
5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting
1998
Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist
1999
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial
2004
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting
2000
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis
2007
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
1995
Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs
2006
Transfer of Sulfur: From Simple to Diverse
2013 Standout
The efficacy of a combination of ondansetron, methyiprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy
1997
Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis
2001
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Use of Antiemetic Agents in Acute Gastroenteritis
2008
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials
2011
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
2009
Ondansetron
2001
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
1996
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice
2003
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
2001
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists
1994
Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy
2006
Ondansetron Oral Disintegrating Tablets: Acceptability and Efficacy in Children Undergoing Adenotonsillectomy
2005
Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
2008
Adjuvant-Carrageenan-Induced Inflammation in Mice
1997
Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
2009
Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune response
2006 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry
2016 Standout
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis? Systematic Re-Evaluation of Clinical Evidence and Drug Cost Implications
2005
Anticancer Drug-Loaded Gliadin Nanoparticles Induce Apoptosis in Breast Cancer Cells
2012
Impact of guidelines implemented in a Paris university hospital: application to the use of antiemetics by cancer patients
1999
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Main properties and current applications of some polysaccharides as biomaterials
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence
2000
Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting
2004
Cannabinoids for Medical Use
2015 Standout
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
2008
Prostaglandins and Inflammation
2011 Standout
Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone
2001
Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis
1995
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of W. Paska being referenced
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis
1996
Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study
1994
Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study
1999
Role of Ondansetron plus Dexamethasone in Fractionated Chemotherapy
1993
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder
2003
Studies on type II collagen induced arthritis in mice
1986
Antiemetic activity of ondansetron in acute gastroenteritis
1997